Navigation Links
Data From Two Phase 3 Studies Show Anti-TNF Golimumab Significantly Improved Signs and Symptoms of Rheumatoid Arthritis
Date:6/11/2008

ab was generally well-tolerated in RA patients. Through week 16, 61 percent, 63 percent, 69 percent and 70 percent of patients receiving placebo plus MTX, golimumab 100 mg plus placebo, golimumab 50 mg plus MTX and golimumab 100 mg plus MTX, respectively, reported at least one adverse event (AE). Three patients participating in the study developed malignancies: one patient taking golimumab 100 mg plus MTX developed breast cancer, one patient taking golimumab 100 mg plus placebo developed Bowen's disease and one patient taking placebo plus MTX developed basal cell carcinoma. There were no reports of opportunistic infection or tuberculosis.

About the GO-BEFORE Trial

GO-BEFORE, a Phase 3, multi-center, double-blind, placebo controlled study included 637 MTX-naive adults with RA. Patients with active RA who had more than four tender and swollen joints were included in the multicenter study. Adult patients were randomly assigned into four groups to receive placebo every four weeks plus MTX 20 mg per week (Group 1), golimumab 100 mg every four weeks plus placebo every week (Group 2), golimumab 50 mg every four weeks plus MTX 20 mg per week (Group 3), or golimumab 100 mg every four weeks plus MTX 20 mg per week (Group 4).

AEs were generally similar across the four patient groups. Through week 24, serious infections were reported in 2 percent, 1 percent, 1 percent and 4 percent of Groups 1-4, respectively. Four patients reported malignancies during the study: two patients from Group 1 and one patient each from Groups 3 and 4. There were also two deaths during the study -- one patient in Group 3 committed suicide, and one patient from Group 4 died from cardiac arrest following a surgical procedure. Overall, serious AEs were reported in 7 percent, 3 percent, 6 percent and 6 percent of patients in Groups 1-4, respectively.

Anti-TNF therapies have been associated with serious and sometimes fatal risks, including the risk of tuberculosis and other ser
'/>"/>

SOURCE Centocor
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... 17, 2014 The ambulance equipment ... decade due to the recession, an unstable ... advancements. This BCC Research report analyzes present ... the ambulance and emergency medical services equipment ... hemorrhage control devices, equipment used for burn ...
(Date:9/17/2014)... , Sept. 17, 2014  Dr. Stephen ... the White House today for National Recovery Month, stars ... consumer advocates released today. Consumer advocates were also joined ... who spoke out after losing her fiancée because of ... the doctor had a history of crack cocaine abuse. ...
(Date:9/17/2014)... 17, 2014 /PRNewswire-iReach/ -- ChemImage announced today ... improvements in the development of imaging technology ... normal and diseased tissue that minimizes the ... procedures, lowers surgical costs and potentially enhances ... The clinical and scientific teams ...
Breaking Medicine Technology:Ambulance and Emergency Equipment: Global Markets 2Ambulance and Emergency Equipment: Global Markets 3Ambulance and Emergency Equipment: Global Markets 4Doctor Recovering From 100-Pill-A-Day Addiction Stars In New Ad Supporting Prop 46; Appears At White House for National Recovery Month, Says Consumer Watchdog Campaign 2Doctor Recovering From 100-Pill-A-Day Addiction Stars In New Ad Supporting Prop 46; Appears At White House for National Recovery Month, Says Consumer Watchdog Campaign 3Patient Outcomes Improve When Molecular Chemical Imaging Technology Is Used to Aid Robotic Surgical Procedures, According to New White Paper 2
... Calif., Dec. 5, 2011  Radient Pharmaceuticals Corporation  (OTCQX:RXPC) ... In Vitro Diagnostic (IVD) cancer test, announced ... the 2012 Gastrointestinal Cancers Symposium (ASCO Conference) were ... The meeting will be held on January 19-21, ...
... (NASDAQ and MTA: CTIC) announced today an update on ... application ("MAA") for Pixuvri. CTI is seeking a license ... relapsed or refractory aggressive non-Hodgkin,s lymphoma ("NHL") who have ... received the CHMP,s day 180 list of outstanding issues, ...
Cached Medicine Technology:Radient Pharmaceuticals' Two Abstracts Submitted to 2012 Gastrointestinal Cancers Symposium (ASCO) Regarding Onko-Sure® Utility in Colorectal Cancer Are Accepted for Presentation 2Radient Pharmaceuticals' Two Abstracts Submitted to 2012 Gastrointestinal Cancers Symposium (ASCO) Regarding Onko-Sure® Utility in Colorectal Cancer Are Accepted for Presentation 3European Medicines Agency's (EMA) Committee for Human Medicinal Products (CHMP)Tentatively Scheduled to Render an Opinion on PixuvriTM Marketing Authorization Application on January 19, 2012 2European Medicines Agency's (EMA) Committee for Human Medicinal Products (CHMP)Tentatively Scheduled to Render an Opinion on PixuvriTM Marketing Authorization Application on January 19, 2012 3European Medicines Agency's (EMA) Committee for Human Medicinal Products (CHMP)Tentatively Scheduled to Render an Opinion on PixuvriTM Marketing Authorization Application on January 19, 2012 4European Medicines Agency's (EMA) Committee for Human Medicinal Products (CHMP)Tentatively Scheduled to Render an Opinion on PixuvriTM Marketing Authorization Application on January 19, 2012 5
(Date:9/17/2014)... 2014 As kinship care continues to ... cannot live with their parents, emphasis on kinship care ... enhance services and supports for kinship caregivers and families. ... Kinship Care Conference is being held this week in ... practice, policy, program and service development for kinship caregivers, ...
(Date:9/17/2014)... reserved for the very healthy. Astronauts are selected ... and psychological standards to prepare them for any ... spaceflight, average people can now fly for enjoyment. ... information about what medical conditions or diseases should ... as most medical conditions have never been studied ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 People who struggle ... now head to http://www.perwickstrom.com and get the answer ... thing to point out, is that a business plan and ... they work together, commented Per Wickstrom. “The way I view ... by a business strategy which is part two.” , ...
(Date:9/17/2014)... Bioluminescence, nanoparticles, gene manipulation these sound like ... in fact, they are components of an exciting ... In preclinical animal models of metastatic prostate cancer, ... VCU Institute of Molecular Medicine and Johns Hopkins ... molecular imaging approach that could revolutionize doctors, ability ...
(Date:9/17/2014)... September 17, 2014 Catalent Pharma ... technologies and development solutions for drugs, biologics and ... OptiPact™, an integrated service and technology offer based ... provided from the company’s 450,000 sq. ft. Kansas ... ability to integrate optimal formulation, development, analytical expertise, ...
Breaking Medicine News(10 mins):Health News:Arizona’s Children Association Kinship Service Providers Invited to Present at the CWLA National Conference 2Health News:Space: The final frontier… open to the public 2Health News:Per Wickstrom’s Latest Blog Explores the Difference Between a Business Plan and a Business Strategy 2Health News:New non-invasive technique could revolutionize the imaging of metastatic cancer 2Health News:New non-invasive technique could revolutionize the imaging of metastatic cancer 3Health News:New OptiPact™ Technology Introduced by Catalent 2
... , PTs and PTAs listed as occupations that will "likely ... July 21 The nation,s aging population and expanded health care coverage ... Physical Therapy Association (APTA) as a new federal report (1) that presents ... next 5 to 10 years is released. , ...
... , MINNEAPOLIS and COLUMBUS, Ohio, ... MEDNETWorld.com (MEDNET), a leader in Nationwide Health ... with The Rubicon Group, eHealth Ohio, Bostech Corporation and ... (HPOC) Service enabling interoperable electronic exchange of clinical data ...
... 21 , , Rochester Medical Corporation ... on Thursday July 30, 2009. The Company will then hold a quarterly ... 3:30 p.m. central time (4:30 p.m. eastern time). , , ... at Rochester Medical,s website at www.rocm.com . To listen ...
... , ANDOVER, Mass., July 21 ... that serves the Texas Midwest area, finished its implementation of ... for advanced authentication. Following its enterprise roll-out of Sentillion,s ... Go to enable caregivers in its trauma center to use ...
... Texas, July 21 GVI Security Solutions, Inc. (OTC Bulletin ... featuring the complete Samsung Electronics line of products, announced that ... video surveillance solution for a North East pharmacy chain. , ... surveillance solution is based on GVI Samsung high performance/low light ...
... , , ... Advice Networks , the nation,s leading provider of physician ... state-of-the-art wireless broadband technology solution that delivers real-time health ... flat-screen monitors. Strategically located in the back office, medical ...
Cached Medicine News:Health News:President's Council Projects Growth For Physical Therapy Profession 2Health News:Partnership Collaborates on HIE for Interoperability of Electronic Health Records and Patient Data in Ohio 2Health News:Rochester Medical Announces Third Quarter 2009 Earnings Conference Call July 30, 2009 2Health News:Hendrick Health System Deploys Sentillion's Tap & Go Advanced Authentication Solution 2Health News:Hendrick Health System Deploys Sentillion's Tap & Go Advanced Authentication Solution 3Health News:GVI Security Solutions Samsung Video Surveillance Solution Selected by North East Pharmacy Chain 2Health News:Healthy Advice Networks Announces the Launch of PracticeWire; Technology to Deliver Real-time Healthcare Content to Physicians 2
The CGIL iridectomy contact glass was designed by Riquin, Fankhauser et al. to perform full thickness peripheral laser iridectomies....
The CGVL vitrectomy contact glass was designed by Rol, Fankhauser et al. for photodisruptive YAG laser procedures in the posterior vitreous....
For newly born children 10 mm internal diameter of the cornea part. Designed to work with argon/YAG Lasers....
... The HAAG-STREIT OM 900 Ophthalmometer uses ... the three requirements of Helmholtz: 1. The ... of the distance between the Ophthalmometer and ... are independent of the distance between the ...
Medicine Products: